Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, DANYAL HASSAN | 1 | 66.7% | +0.0% |
| KASSA, TIGABU | 1 | 36.5% | +28.2% |
| ESPINOSA, CLAUDIA EDILMA | 1 | 51.9% | +56.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18272307 | PROPHYLACTIC ADMINISTRATION METHOD AGAINST RESPIRATORY VIRUS, COMPRISING ADMINISTERING INTERFERON-BETA TO POTENTIAL RESPIRATORY VIRUS-INFECTED SUBJECT | ALAM, DANYAL HASSAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267459 | METHOD FOR PREPARING PHARMACEUTICAL FORMULATION OF TABLET CONTAINING TRIZOLOPYRAZINE DERIVATIVE AS AN ACTIVE INGREDIENT | KASSA, TIGABU | — |
| 17627840 | METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN | ESPINOSA, CLAUDIA EDILMA | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| 1619 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18272307 | PROPHYLACTIC ADMINISTRATION METHOD AGAINST RESPIRATORY VIRUS, COMPRISING ADMINISTERING INTERFERON-BETA TO POTENTIAL RESPIRATORY VIRUS-INFECTED SUBJECT | ALAM, DANYAL HASSAN | 1675 | §103§112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18267459 | METHOD FOR PREPARING PHARMACEUTICAL FORMULATION OF TABLET CONTAINING TRIZOLOPYRAZINE DERIVATIVE AS AN ACTIVE INGREDIENT | KASSA, TIGABU | 1619 | §103 | Final Rejection | — | Pending | Jun 15, 2023 |
| 17627840 | METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN | ESPINOSA, CLAUDIA EDILMA | 1654 | §103 | Non-Final OA | — | Pending | Jan 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial